Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Remyelination Therapy in Multiple Sclerosis.
[Oral disease-modifying agents in relapsing-remitting multiple sclerosis].
Alternatives for reducing relapse rate when switching from natalizumab to fingolimod in multiple sclerosis.
Hyaluronidase and Hyaluronan Oligosaccharides Promote Neurological Recovery after Intraventricular Hemorrhage.
Lesion Expansion in Experimental Demyelination Animal Models and Multiple Sclerosis Lesions.
Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid cause demyelination of spinal cord explants.
Marijuana Legalization: Impact on Physicians and Public Health.
Safety, anxiety and natalizumab continuation in JC virus-seropositive MS patients.
Cerebrospinal fluid derived from progressive multiple sclerosis patients promotes neuronal and oligodendroglial differentiation of human neural precursor cells in vitro.
No evidence for shared genetic basis of common variants in multiple sclerosis and amyotrophic lateral sclerosis.
Transcriptional Regulation of Brain-Derived Neurotrophic Factor (BDNF) by Methyl CpG Binding Protein 2 (MeCP2): a Novel Mechanism for Re-Myelination and/or Myelin Repair Involved in the Treatment of Multiple Sclerosis (MS).
Th17 cells in autoimmune diseases.
Inhibition of UCH-L1 in oligodendroglial cells results in microtubule stabilization and prevents α-synuclein aggregate formation by activating the autophagic pathway: implications for multiple system atrophy.
Modeling the Presence of Myelin and Edema in the Brain Based on Multi-Parametric Quantitative MRI.
HLA genes as modifiers of response to IFN-β-1a therapy in relapsing-remitting multiple sclerosis.
Dietary phytochemicals and neuro-inflammaging: from mechanistic insights to translational challenges.
[Multiple sclerosis: a comprehensive treatment and rehabilitation].
Targeting thalamic tremor cells in deep brain stimulation for multiple sclerosis-induced complex tremor.
[Factors associated to the work situation of patients with multiple sclerosis].
Seizure in Iranian patients with multiple sclerosis.
Diagnosis of asymptomatic natalizumab-associated PML: are we between a rock and a hard place?
Helminth/Parasite treatment of multiple sclerosis.
Energy crisis: The role of oxidative phosphorylation in acute inflammation and sepsis.
A report from the American Academy of Neurology 2014 Annual Meeting (April 26-May 3 - Philadelphia, Pennsylvania, USA).
Dramatically changing rates and reasons for hospitalization in multiple sclerosis.

Pages